[{"Assets_0_Q2_USD":"5302110000.0","CIK":"1048477","CommonStockSharesConverted_0_Q2_shares":"181148332.0","CommonStockSharesOutstanding_0_Q2_shares":"181148332.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.16","EarningsPerShareBasic_2_Q2_USD":"0.29","EarningsPerShareDiluted_1_Q2_USD":"-0.16","EarningsPerShareDiluted_2_Q2_USD":"0.28","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"12543000.0","NetIncomeLossConverted_1_Q2_USD":"-29183000.0","NetIncomeLossConverted_2_Q2_USD":"52198000.0","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_1_Q2_USD":"429485000.0","RevenuesConverted_2_Q2_USD":"931554000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q2_USD":"3236679000.0","Ticker":"BMRN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"180729000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"184344000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"180729000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"180314000.0","filed":"20200805","footnote":null,"form":"10-Q","fp":"Q2","fy":"2020.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20200630","qtrs":"1","uom":"USD"}]